The Asia Pacific gynecological device market will continue to expand through 2029 due to growing patient awareness of gynecologic treatments in this region. In particular, rising awareness of minimally invasive procedures in China and India, where these techniques have been underpenetrated, will result in increased adoption of associated devices. However, the impact of the COVID-19 pandemic, will limit the pace of revenue expansion.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for gynecological devices in Asia Pacific region across a 10-year period.
COVID-19 pandemic will have a negative impact on the gynecological device market.
How will COVID-19 pandemic affect the different segments of the gynecological device market?
When will the market start to recover and at what pace will it do so?
Local competitors are taking advantage of favorable government policies, their strong domestic distribution networks, and lower manufacturing costs to penetrate the Asia Pacific market.
Which companies are seeing success by following this strategy?
Which MNCs are at risk of losing share to domestic manufacturers?
Some market segments are being negatively impacted by product safety concerns.
Which market segments are being impacted by safety concerns?
In which countries are these markets highly affected by these concerns, and in which countries are these markets less affected?
A number of improvements have been made to products across the gynecological device market.
Which companies have made upgrades to their current products?
How will this impact other competitors in the market?
Which markets will be impacted the most?
- Gynecological Devices - Market Insights - Asia Pacific
Author(s): Vijjapu Kameswara Rao, MS Pharm
Vijjapu Kameswara Rao is a research associate on the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at DRG (Part of Clarivate), specializing in the gynecological device market. Kamesh holds a Bachelor's degree in Pharmaceutical Sciences from the Jawaharlal Nehru Technological University Kakinada and a Master's degree in Pharmaceutical Analysis from the National Institute of Pharmaceutical Education and Research, Mohali.